SCHEMBL29216272

SCHEMBL29216272

CCC[C@H](N[C@H]1CCc2cc(Cl)cc(F)c2C1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 11/20 0.47
PSEN2 P49810 11/20 0.47
APH1B Q8WW43 11/20 0.47
NCSTN Q92542 11/20 0.47
APH1A Q96BI3 11/20 0.47
PSENEN Q9NZ42 11/20 0.47
GSAP A4D1B5 1/20 0.46
ACE P12821 1/20 0.38
CDK9 P50750 2/20 0.38
CCNT1 O60563 1/20 0.37
ADRB1 P08588 2/20 0.35
ADRB3 P13945 2/20 0.35
HTR1A P08908 2/20 0.35
DRD2 P14416 1/20 0.35
PTPN2 P17706 1/20 0.34
PTPN1 P18031 1/20 0.34
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29216277 1.00 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29216274 1.00 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL26374336 0.89 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5122501 0.89 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2826108 0.89 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2980171 0.89 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5120616 0.89 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5120622 0.89 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1800302 0.89 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL26374403 0.88 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399203-A1 CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS Springworks Therapeutics, Inc. (US) 2024-07-17 EP disclosed
CN-118043311-A Chlorinated tetralin compounds and pharmaceutical compositions 斯普林渥克斯治疗有限公司 2024-05-14 CN disclosed
US-20230090557-A1 CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS SPRINGWORKS THERAPEUTICS INC (US) 2023-03-23 US disclosed
WO-2023039475-A1 CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS SPRINGWORKS THERAPEUTICS, INC. (US) 2023-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230090557-A1 CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TCOF1, TTL, CCDC47 PSEN1 408/4885PSEN2 245/4885APH1B 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.